MedTrace Logo

Oral Mucosal Absorption of ICI176,334-1

NCT01415791 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2012-05-30

No results posted yet for this study

Summary

The purpose of this study is to investigate the presence or absence of oral mucosal absorption of ICI176,334-1

Conditions

  • Healthy

Interventions

DRUG

ICI176,334-1

Subject will receive single dose of ICI176,334-1

Sponsors & Collaborators

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-09-30
Completion
2011-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01415791 on ClinicalTrials.gov